Jennifer Adrian

Experience

• 

  Director, External Manufacturing

  Kyverna Therapeutics • Current • Jul 2023 - Present

  Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis,…

• CMC Lead

  CRISPR Therapeutics • Previous • Feb 2023 - Jul 2023

• Additional experience 1
• Additional experience 2